Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $21.6800 (-3.04%) ($21.6800 - $21.6800) on Thu. Aug. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.91% (three month average) | RSI | 8 | Latest Price | $21.6800(-3.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -9.4% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(70%) ARKG(65%) ARKK(60%) IBB(60%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -1.955% in a week (0% probabilities). VIXM(-46%) VXX(-40%) UUP(-20%) IGOV(-8%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.955% (StdDev 3.91%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-17.77(-181.96%) | Resistance Level | $26.73 | 5 Day Moving Average | $22.27(-2.65%) | 10 Day Moving Average | $22.53(-3.77%) | 20 Day Moving Average | $26.73(-18.89%) | To recent high | -46.4% | To recent low | 0% | Market Cap | $2.746b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |